159 related articles for article (PubMed ID: 23792426)
1. XIAP: inhibitor of two worlds.
Merlo P; Cecconi F
EMBO J; 2013 Aug; 32(16):2187-8. PubMed ID: 23792426
[TBL] [Abstract][Full Text] [Related]
2. XIAP inhibits autophagy via XIAP-Mdm2-p53 signalling.
Huang X; Wu Z; Mei Y; Wu M
EMBO J; 2013 Aug; 32(16):2204-16. PubMed ID: 23749209
[TBL] [Abstract][Full Text] [Related]
3. Dynamics in the p53-Mdm2 ubiquitination pathway.
Brooks CL; Gu W
Cell Cycle; 2004 Jul; 3(7):895-9. PubMed ID: 15254415
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of MDM2 inhibitor MI-219 against lung cancer cells alone or in combination with MDM2 knockdown, a XIAP inhibitor or etoposide.
Zheng M; Yang J; Xu X; Sebolt JT; Wang S; Sun Y
Anticancer Res; 2010 Sep; 30(9):3321-31. PubMed ID: 20944104
[TBL] [Abstract][Full Text] [Related]
5. BMPR2 inhibition induced apoptosis and autophagy via destabilization of XIAP in human chondrosarcoma cells.
Jiao G; Guo W; Ren T; Lu Q; Sun Y; Liang W; Ren C; Yang K; Sun K
Cell Death Dis; 2014 Dec; 5(12):e1571. PubMed ID: 25501832
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous activation of p53 and inhibition of XIAP enhance the activation of apoptosis signaling pathways in AML.
Carter BZ; Mak DH; Schober WD; Koller E; Pinilla C; Vassilev LT; Reed JC; Andreeff M
Blood; 2010 Jan; 115(2):306-14. PubMed ID: 19897582
[TBL] [Abstract][Full Text] [Related]
7. XIAP and cIAP1 amplifications induce Beclin 1-dependent autophagy through NFκB activation.
Lin F; Ghislat G; Luo S; Renna M; Siddiqi F; Rubinsztein DC
Hum Mol Genet; 2015 May; 24(10):2899-913. PubMed ID: 25669656
[TBL] [Abstract][Full Text] [Related]
8. A new function for p53 ubiquitination.
Hirano Y; Ronai Z
Cell; 2006 Nov; 127(4):675-7. PubMed ID: 17110328
[TBL] [Abstract][Full Text] [Related]
9. Triptolide sensitizes AML cells to TRAIL-induced apoptosis via decrease of XIAP and p53-mediated increase of DR5.
Carter BZ; Mak DH; Schober WD; Dietrich MF; Pinilla C; Vassilev LT; Reed JC; Andreeff M
Blood; 2008 Apr; 111(7):3742-50. PubMed ID: 18187663
[TBL] [Abstract][Full Text] [Related]
10. Regulation of the Mdm2-p53 pathway by the ubiquitin E3 ligase MARCH7.
Zhao K; Yang Y; Zhang G; Wang C; Wang D; Wu M; Mei Y
EMBO Rep; 2018 Feb; 19(2):305-319. PubMed ID: 29295817
[TBL] [Abstract][Full Text] [Related]
11. Life, death, and ubiquitin: taming the mule.
Shmueli A; Oren M
Cell; 2005 Jul; 121(7):963-5. PubMed ID: 15989944
[TBL] [Abstract][Full Text] [Related]
12. A network of substrates of the E3 ubiquitin ligases MDM2 and HUWE1 control apoptosis independently of p53.
Kurokawa M; Kim J; Geradts J; Matsuura K; Liu L; Ran X; Xia W; Ribar TJ; Henao R; Dewhirst MW; Kim WJ; Lucas JE; Wang S; Spector NL; Kornbluth S
Sci Signal; 2013 May; 6(274):ra32. PubMed ID: 23652204
[TBL] [Abstract][Full Text] [Related]
13. Regulation of the p53-MDM2 pathway by 14-3-3 sigma and other proteins.
Lee MH; Lozano G
Semin Cancer Biol; 2006 Jun; 16(3):225-34. PubMed ID: 16697215
[TBL] [Abstract][Full Text] [Related]
14. microRNA-1827 represses MDM2 to positively regulate tumor suppressor p53 and suppress tumorigenesis.
Zhang C; Liu J; Tan C; Yue X; Zhao Y; Peng J; Wang X; Laddha SV; Chan CS; Zheng S; Hu W; Feng Z
Oncotarget; 2016 Feb; 7(8):8783-96. PubMed ID: 26840028
[TBL] [Abstract][Full Text] [Related]
15. Regulating the p53 pathway: in vitro hypotheses, in vivo veritas.
Toledo F; Wahl GM
Nat Rev Cancer; 2006 Dec; 6(12):909-23. PubMed ID: 17128209
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of dual MDM2/XIAP inhibitors based on the tetrahydroquinoline scaffold.
Albadari N; Xie Y; Liu T; Wang R; Gu L; Zhou M; Wu Z; Li W
Eur J Med Chem; 2023 Jul; 255():115423. PubMed ID: 37130471
[TBL] [Abstract][Full Text] [Related]
17. Regulation of XIAP translation and induction by MDM2 following irradiation.
Gu L; Zhu N; Zhang H; Durden DL; Feng Y; Zhou M
Cancer Cell; 2009 May; 15(5):363-75. PubMed ID: 19411066
[TBL] [Abstract][Full Text] [Related]
18. CARPs are ubiquitin ligases that promote MDM2-independent p53 and phospho-p53ser20 degradation.
Yang W; Rozan LM; McDonald ER; Navaraj A; Liu JJ; Matthew EM; Wang W; Dicker DT; El-Deiry WS
J Biol Chem; 2007 Feb; 282(5):3273-81. PubMed ID: 17121812
[TBL] [Abstract][Full Text] [Related]
19. MDM2 as a target for ellagic acid‑mediated suppression of prostate cancer cells in vitro.
Mohammed Saleem YI; Selim MI
Oncol Rep; 2020 Sep; 44(3):1255-1265. PubMed ID: 32705219
[TBL] [Abstract][Full Text] [Related]
20. Regulation of the MDM2-p53 pathway by the ubiquitin ligase HERC2.
García-Cano J; Sánchez-Tena S; Sala-Gaston J; Figueras A; Viñals F; Bartrons R; Ventura F; Rosa JL
Mol Oncol; 2020 Jan; 14(1):69-86. PubMed ID: 31665549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
